These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 34491934)

  • 1. MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review.
    Santilli A; Stitt D
    Neurologist; 2021 Sep; 26(5):175-177. PubMed ID: 34491934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW; Morsch M; Phillips WD
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.
    Guptill JT; Sanders DB
    Curr Opin Neurol; 2010 Oct; 23(5):530-5. PubMed ID: 20613516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbid Human Immunodeficiency Virus (HIV) and Muscle-Specific Kinase (MuSK) Myasthenia Gravis: A Case Report and Literature Review.
    Sherpa M; Metai RK; Kumar V; Hirachan T; Ahmed KU; Atkinson SJ
    Am J Case Rep; 2017 Apr; 18():427-430. PubMed ID: 28424453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of MuSK Myasthenia Gravis Presenting With Persistent Respiratory Insufficiency.
    Tsai C; Howard JF; Mehrabyan A
    J Clin Neuromuscul Dis; 2021 Sep; 23(1):39-42. PubMed ID: 34431800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.
    Morren J; Li Y
    Muscle Nerve; 2018 Sep; 58(3):344-358. PubMed ID: 29461627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review.
    Pugliese A; Nicocia G; Messina S; Toscano A; Rodolico C
    Neuromuscul Disord; 2023 Feb; 33(2):145-147. PubMed ID: 36628839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MuSK myasthenia gravis with prolonged remission.
    Bouwyn JP; Magnier P; BĂ©dat-Millet AL; Ahtoy P; MaltĂȘte D; Lefaucheur R
    Neuromuscul Disord; 2016 Jul; 26(7):453-4. PubMed ID: 27161384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis with antibodies to MuSK: an update.
    Evoli A; Alboini PE; Damato V; Iorio R; Provenzano C; Bartoccioni E; Marino M
    Ann N Y Acad Sci; 2018 Jan; 1412(1):82-89. PubMed ID: 29266255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Report of MuSK Antibody-Positive Myasthenia Gravis.
    Gayathri D; Nandasiri S; Pathirana G
    Cureus; 2024 Jun; 16(6):e61820. PubMed ID: 38975540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis.
    Bekooij TJS; Gilhuis HJ; Dawson L; Niks EH
    J Neuromuscul Dis; 2020; 7(1):47-50. PubMed ID: 31868676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report.
    Sakano S; Matsuyama H; Ishikawa H; Shindo A; Ii Y; Matsuura K; Mizutani M; Kawada N; Tomimoto H
    BMC Neurol; 2020 Jun; 20(1):240. PubMed ID: 32532281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
    Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
    Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study.
    Modoni A; Mastrorosa A; Spagni G; Evoli A
    Clin Neurophysiol; 2021 Aug; 132(8):1845-1849. PubMed ID: 34147009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
    Triplett JD; Hardy TA; Riminton DS; Chu SYK; Reddel SW
    Muscle Nerve; 2019 Sep; 60(3):307-311. PubMed ID: 31177576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
    Yamada C; Teener JW; Davenport RD; Cooling L
    J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.